Ukr.Biochem.J. 2026; Volume 98, Issue 4, Jul-Aug, pp. 44-50

doi: https://doi.org/10.15407/ubj98.04.044

Role of fibrinogen and fibrin in initiation of thrombin generation

A. V. Udovenko, Ye. M. Makogonenko, V. O. Chernyshenko

Palladin Institute of biochemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine;
*e-mail: nudovenko26@gmail.com

Received: 07 May 2026; Revised: 27 June 2026;
Accepted: 27 July 2026; Available on-line: 04 August 2026

Background. Thrombin is the key enzyme of blood coagulation that converts fibrinogen into fibrin and activates multiple coagulation factors. However, the temporal relationship between thrombin-mediated fibrin formation and the availability of thrombin for other physiological substrates during the initiation of coagulation remains insufficiently understood. Objective. To investigate the role of fibrinogen and fibrin in regulating thrombin activity during the initiation phase of thrombin generation in plasma. Methods. Thrombin generation was initiated in human plasma using activated partial thromboplastin time (APTT) reagent or Thromborel. Fibrin formation was monitored turbidimetrically at 405 nm. Thrombin amidolytic activity toward the chromogenic substrate S2238 was measured spectrophotometrically at 405 nm. Fibrin polymerization was inhibited with the synthetic peptide GPRP. The effects of plasma dilution and inhibition of fibrin polymerization on the temporal profiles of fibrin formation and thrombin activity were analyzed. Results. During initiation of thrombin generation with both APTT-reagent and Thromborel, the beginning of cleavage of S2238 by thrombin coincided with the end of fibrin clot formation, marked by turbidimetric curve. At 1:3 plasma dilution, fibrin formation lag time was 210 s, amidase activity lag phase was 410 s. At 1:10 dilution, the lag time for fibrin formation was 73 s, amidase activity was 200 s, indicating that dilution (and lower fibrinogen) accelerates thrombin generation. With 1 mM GPRP, fibrin and amidase activity lag times increased by an order of magnitude. Conclusions. Thrombin generated during initiation of thrombin generation acts primarily on fibrinogen, remaining bound to the molecule throughout its conversion into fibrin and clot formation. Its amidase activity emerges only after protofibrils undergo lateral association into fibrin clot. Once the binding sites in the fibrin clot are saturated, thrombin becomes available for other substrates (FV, FVIII, FXI) and physiological functions.

Keywords: , , ,


References:

  1. Al-Amer OM. The role of thrombin in haemostasis. Blood Coagul Fibrinolysis. 2022;33(3):145-148. PubMed, CrossRef
  2. Pieters M, Wolberg AS. Fibrinogen and fibrin: An illustrated review. Res Pract Thromb Haemost. 2019;3(2):161-172. PubMed, PubMedCentral, CrossRef
  3. Crossen J, Shankar KN, Diamond SL. Investigating thrombin-loaded fibrin in whole blood clot microfluidic assay via fluorogenic peptide. Biophys J. 2023;122(4):697-712. PubMed, PubMedCentral, CrossRef
  4. Risman RA, Belcher HA, Ramanujam RK, Weisel JW, Hudson NE, Tutwiler V. Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen. Biomolecules. 2024;14(2):230. PubMed, PubMedCentral, CrossRef
  5. Park S, Park JK. Back to basics: the coagulation pathway. Blood Res. 2024;59(1):35. PubMed, PubMedCentral, CrossRef
  6. Troisi R, Balasco N, Autiero I, Sica F, Vitagliano L. New insight into the traditional model of the coagulation cascade and its regulation: illustrated review of a three-dimensional view. Res Pract Thromb Haemost. 2023;7(6):102160. PubMed, PubMedCentral, CrossRef
  7. Suzuki K. Thrombomodulin: A key regulator of intravascular blood coagulation, fibrinolysis, and inflammation, and a treatment for disseminated intravascular coagulation. Proc Jpn Acad Ser B Phys Biol Sci. 2025;101(2):75-97. PubMed, PubMedCentral, CrossRef
  8. Olgasi C, Assanelli S, Cucci A, Follenzi A. Hemostasis and endothelial functionality: the double face of coagulation factors. Haematologica. 2024;109(7):2041-2048. PubMed, PubMedCentral, CrossRef
  9. van Hinsbergh VW. Endothelium–role in regulation of coagulation and inflammation. Semin Immunopathol. 2012;34(1):93-106. PubMed, PubMedCentral, CrossRef
  10. Depasse F, Binder NB, Mueller J, Wissel T, Schwers S, Germer M, Hermes B, Turecek PL. Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine. J Thromb Haemost. 2021;19(12):2907-2917. PubMed, PubMedCentral, CrossRef
  11. Valke LLFG, Rijpma S, Meijer D, Schols SEM, van Heerde WL. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases. Front Cardiovasc Med. 2022;9:1033416. PubMed, PubMedCentral, CrossRef
  12.  Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci. 2008;38(1):15-23. PubMed, PubMedCentral, CrossRef
  13. Lakshmanan HHS, Estonilo A, Reitsma SE, Melrose AR, Subramanian J, Zheng TJ, Maddala J, Tucker EI, Gailani D, McCarty OJT, Jurney PL, Puy C. Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXI. J Thromb Haemost. 2022;20(6):1350-1363. PubMed, PubMedCentral, CrossRef
  14. Sidonio RF Jr, Hoffman M, Kenet G, Dargaud Y. Thrombin generation and implications for hemophilia therapies: A narrative review. Res Pract Thromb Haemost. 2022;7(1):100018. PubMed, PubMedCentral, CrossRef
  15. Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009;108(5):1433-1446. PubMed, CrossRef
  16. Rijken DC, Uitte de Willige S. Inhibition of Fibrinolysis by Coagulation Factor XIII. Biomed Res Int. 2017;2017:1209676. PubMed, PubMedCentral, CrossRef
  17. Singh S, Saleem S, Reed GL. Alpha2-Antiplasmin: The Devil You Don’t Know in Cerebrovascular and Cardiovascular Disease. Front Cardiovasc Med. 2020;7:608899. PubMed, PubMedCentral, CrossRef
  18. Duarte RCF, Ferreira CN, Rios DRA, Reis HJD, Carvalho MDG. Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations. Rev Bras Hematol Hemoter. 2017;39(3):259-265. PubMed, PubMedCentral, CrossRef
  19. Storozhuk BG, Pyrogova LV, Chernyshenko TM, Kostiuchenko OP, Kolesnikova IM, Platonova TM, Storozhuk OB, Storozhuk LO, Bereznitsky GK, Tsap PYu, Masenko OO, Makogonenko EM, Lugovskoy EV. Overall hemostasis potential of the blood plasma and its relation to some molecular markers of the hemostasis system in patients with chronic renal disease of stage VD. Ukr Biochem J. 2018;90(5):60-70. CrossRef
  20. Gornitskaia OV, Rovinskaya IN, Platonova TN. Purification and characterization of the fibrinolytic enzyme from Agkistrodon halys halys venom. Ukr Biokhim Zhurn. 2002;74(3):42-49. (In Russian). PubMed
  21. Tillman B, Gailani D. Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces. Semin Thromb Hemost. 2018;44(1):60-69. PubMed, PubMedCentral, CrossRef
  22. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost. 2003;89(1):9-12. PubMed
  23. Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA. 1978;75(7):3085-3089. PubMed, PubMedCentral, CrossRef
  24. Hulshof AM, Hemker HC, Spronk HMH, Henskens YMC, Ten Cate H. Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis. Int J Mol Sci. 2021;22(5):2590. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.